Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market

Investors

InVasc Therapeutics, Inc. is a privately held company. Up to this point in time the Company has been financed directly by the founders, their friends and family.

The Company anticipates that it will raise additional capital sometime during 2010. For more information about InVasc please contact us at (678) 736-5907.

InVasc plans a Series A round in

early 2010

 

Investor Relations

Investors

Strategic Partners